Evaluation of the clinical effect of Qinghua Xiaoyafang in improving the preoperative inflammatory state of patients with Crohn's disease and anal fistula
- Conditions
- Crohn disease
- Registration Number
- ITMCTR2100004355
- Lead Sponsor
- Shuguang Hospital Affiliated to Shanghai University of traditional Chinese medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Patients in Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine who met the above-mentioned diagnosis of Crohn's disease, diagnosed anal fistula by perianal magnetic resonance, and were in the active stage of Crohn's disease.
2. Age from 16 to 65 years old. Because Crohns disease occurs more often in adolescents, the lower age limit is set to 16 years old.
3. Obtain informed consent of patients.
1. Patients with colorectal tumors, lymphomas and other diseases;
2. Patients with serious underlying diseases, heart, lung and kidney;
3. Patients with severe mental illness or poor compliance who cannot cooperate with the research plan;
4. Patients with active infections such as viral hepatitis, tuberculosis, and enteric infectious diseases;
5. Female patients during lactation and pregnancy.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Crohn disease activity index, CDAI;
- Secondary Outcome Measures
Name Time Method